Professional development Vacancies

Sirdalud (tizanidine)

06.08.2014 Updated 22.10.2019 3766 views

MoH order No. 537 of 01.08.2014 approved the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product containing tizanidine, namely Sirdalud®, tablets, with amendments and additions.

List of medicinal products containing tizanidine authorized for medical use in Ukraine.

Other materials in this section

All 284 materials of the section
Useful resources
Conferences, Forums, Events
Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"
Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"
Forum "Clinical and preclinical studies in wartime: organization and development prospects"
Forum "Clinical and preclinical studies in wartime: organization and development prospects"
Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"
Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"
PHARMEXPERT 2024. Standards. Innovations. European integration
PHARMEXPERT 2024. Standards. Innovations. European integration
View all
Latest updates

List of registration forms submitted for state re-registration in the period from 26.10.2026 to 30.10.2026
# For applicants # List of applications for state registration of medicinal products
Read more

List of registration forms submitted for state registration in the period from 26.10.2026 to 30.10.2026
# For applicants # List of applications for state registration of medicinal products
Read more

List of medicinal products registered by competent authorities (02.11.2026)
# For applicants # Lists of medicinal products registered by competent authorities
Read more

List of medicinal products submitted to the MoH (02.11.2026)
# For applicants # List of medicinal products recommended for registration, re-registration and variations to registration materials
Read more

Lifeleza, film-coated tablets, Mistral Capital Management Limited, England
# For patients # Pharmacovigilance # RMP summaries # 2026
Read more
All updates for today
Latest Announcements

Updated! Competitive selection of members of the Expert Committee on HTA: deadline for submitting documents – until October 23, 2026

 More details

Updated! List of original (innovative) medicinal products registered in Ukraine as of 02.11.2026

 More details

Attention to business entities engaged in retail trade of medicinal products on the market of Ukraine! We provide lists of over-the-counter medicinal products by their storage conditions

 More details
All Announcements
Latest News
Revised draft documents on eCTD have been published

Revised draft documents on eCTD have been published

 More details
Specialists of the Center studied European approaches to the regulation of medical devices in Denmark

Specialists of the Center studied European approaches to the regulation of medical devices in Denmark

 More details
The Center took part in the Ministry of Health's consultations with the pharmaceutical business on the launch of the Ukrainian Pharma Agency

The Center took part in the Ministry of Health's consultations with the pharmaceutical business on the launch of the Ukrainian Pharma Agency

 More details
All News